Good MorningInvestors and traders got a double-shot of good news from Fed chief Jerome Powell’s second day of testimony on Capitol Hill. In his comments, Mr. Powell both affirmed the need for more stimulus while also indicating the economic recovery is well underway. The pandemic is still a concern as are high levels of joblessness but the general outlook is positive. Add to that a lack of concern for the possibility of rising inflation and it is no surprise the broad market S&P 500 gained 1.0%.
Technically speaking, Wednesday’s gain in the market is a bullish signal. The market made a solid move higher confirming support at a key technical level, the 30-day moving average. The 30-day moving average is a gauge of near-term sentiment and an indication of which direction short-term traders are placing their bets. With the moving average trending higher and support at the average confirmed new all-time highs for the S&P 500 index are all but assured.
Featured: Want This View In YOUR Backyard? Here's How... (Legacy- JCF Campaigns) 
|
Stocks | | |
Now that we’ve seen some volatility in February, it might be time to take a long hard look at your portfolio holdings. If you were feeling very uncomfortable during the recent market weakness, you might be overexposed to things like growth stocks or simply haven’t accurately defined yo... Read the Full Story |
|
From Our PartnersClean-tech stocks are going ballistic as Biden puts the clamps on oil drilling and fracking. Individual investors, just like you, stand to make millions in stock profits simply by buying the best stocks in the Green-Energy space like this one: At just $2 per share, it's the only publicly traded company that stands to make an absolute fortune on clean energy sources without actually producing any. | | More details here... |
|
Politics | | | Global stock markets followed Wall Street higher Thursday after the Federal Reserve chairman said the U.S. central bank is in no hurry to withdraw support for the economy.
London and Frankfurt rose in early trading. Shanghai, Tokyo, Hong Kong and Seoul closed higher. U.S. futures were... Read the Full Story |
|
Politics | | | Asian stock markets followed Wall Street higher Thursday after the Federal Reserve chairman said the U.S. central bank is in no hurry to withdraw support for the economy.
Shanghai, Tokyo, Hong Kong and Seoul all advanced.
Overnight, Wall Street hit a new high after chai... Read the Full Story |
|
From Our PartnersThe firm that called the EXACT PEAK of the dot-com boom has just issued another major prediction.
If you’ve got money invested in the market – and especially in popular tech stocks – this is critical information for the days ahead… | | | | Watch this leaked video before it's removed |
|
Markets | | |
Plug Power (NASDAQ:PLUG) is among the electric vehicle stocks that have faced much of the recent market backlash surrounding technology valuations. With the EV space unplugged at the moment, some companies may be finding new homes at more palatable prices while others are simply recharging for the... Read the Full Story |
|
Politics | | | GENEVA — The World Health Organization’s Europe unit is reporting that about one in 10 people who contracted COVID-19 continue to show “persistent ill health” 12 weeks after infection.
Dr. Hans Kluge, the head of WHO Europe, says much about so-called “long COVID” remains unknown, but... Read the Full Story |
|
|
Politics | | | Republicans rallied solidly against Democrats' proposed $1.9 trillion COVID-19 relief bill as lawmakers awaited a decision by the Senate's parliamentarian that could bolster or potentially kill a pivotal provision hiking the federal minimum wage.
Despite their paper-thin congressiona... Read the Full Story |
|
Markets | | | A public service ad campaign unveiled Thursday aims to convince Americans to get vaccinated against COVID-19, telling them “It's Up to You.”
The campaign by the Ad Council and its partners is focused on those who may be hesitant to get the shots. One print ad reads: “Getting back to h... Read the Full Story |
|
Markets | | | Poultry products producer Pilgrim’s Pride (NYSE: PPC) stock took a hard hit from the 2020 pandemic as shares have yet to recover to pre-COVID levels. However, the COVID-19 vaccine rollouts and loosening of restrictions are helping the Company regain footing on its way to recovery. Shares are o... Read the Full Story |
|
Markets | | | Square Rides Bitcoin To Triple-Digit Growth
Square (NASDAQ:SQ) is an up-and-coming fintech that is benefiting greatly from the shift to eCommerce spurred by the pandemic, and from renewed interest in cryptocurrency. The company, already growing at a significant clip, saw its revenue growth accelera... Read the Full Story |
|
Markets | | | Communications software and IP transport solutions provider Ribbon Communications (NASDAQ: RBBN) stock recently surged to multi-year highs in February 2021. The Company is also recovering from the pandemic as both fundamentals and technicals are turning the corner. The back-to-normal acceleration sp... Read the Full Story |
|
The Early Bird Stock Of The Day Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders that cause severe skeletal, cardiac, and neurological conditions; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born. The company also provides Signatera, a ctDNA blood test for molecular residual disease assessment and surveillance of disease recurrence in patients previously diagnosed with cancer; Altera, a tissue based comprehensive genomic profiling test; Prospera to assess active rejection in patients who have undergone kidney, heart, and lung transplantation; and Renasight, a kidney gene panel test. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics to validate and launch tests. The company offers products through its direct sales force, as well as through a network of laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was founded in 2003 and is headquartered in Austin, Texas. | | View Today's Stock Pick |
|
